EUR 5.8
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | 5.81 Million | 5.4 Million | 3.71 Million | 2.5 Million | 1.16 Million | 1 Million |
Net Income | 4.08 Million | 2.94 Million | 1.4 Million | 1.34 Million | 863.12 Thousand | 611.44 Thousand |
Depreciation & Amortization | 2.9 Million | 2.7 Million | 1.85 Million | 1.25 Million | 1.16 Million | 1 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -4.08 Million | -2.94 Million | -1.4 Million | -1.34 Million | -863.12 Thousand | -611.44 Thousand |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 5.99 Million | 3.51 Million | 6.11 Million | 3.37 Million | 4.74 Million | 2.34 Million |
Cash at end of period | 5.88 Million | 5.99 Million | 3.51 Million | 6.11 Million | 3.37 Million | 4.74 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -102 Thousand | 2.47 Million | -2.59 Million | 2.74 Million | -1.36 Million | 2.39 Million |
Free Cash Flow | 5.81 Million | 5.4 Million | 3.71 Million | 2.5 Million | 1.16 Million | 1 Million |
Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 2.51 Million | 4.08 Million | 1.5 Million | 2.58 Million | 2.94 Million | 2.13 Million |
Depreciation & Amortization | 1.55 Million | 2.9 Million | 1.47 Million | 1.43 Million | 2.7 Million | 1.35 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | - | - | - |
Other non-cash items | -2.51 Million | -4.08 Million | -1.5 Million | -2.58 Million | -2.94 Million | -2.13 Million |
Investing Cash Flow | - | - | - | - | - | - |
Investments in PPE | - | - | - | - | - | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - | - |
Debt repayment | - | - | - | - | - | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | - | - | - | - |
Accounts receivables | - | - | - | - | - | - |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | 5.88 Million | 5.99 Million | 4.02 Million | 5.99 Million | 3.51 Million | 3.88 Million |
Cash at end of period | 5.23 Million | 5.88 Million | 5.88 Million | 4.02 Million | 5.99 Million | 5.99 Million |
Capital Expenditure | - | - | - | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | -656 Thousand | -102 Thousand | 1.86 Million | -1.96 Million | 2.47 Million | 2.1 Million |
Free Cash Flow | 3.1 Million | 5.81 Million | 2.94 Million | 2.87 Million | 5.4 Million | 2.71 Million |
WBI
GPTX
0S6
CONSTRONIC
CFP
HRZN